Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/29/2003US20030099696 Peptides-containing liposomal surfactants
05/29/2003US20030099675 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery
05/29/2003US20030099668 Comprises loading (transfection) immunogenic DNA oligonucleotides for enhanced lymphocyte response; genetic engineering
05/29/2003US20030099664 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099652 Novel human protein tyrosine kinase
05/29/2003US20030099651 Method and pharmaceutical composition for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
05/29/2003US20030099650 Treatment of immune disorders and B cell disorders
05/29/2003US20030099649 Composition and method for treating inflammatory disorders
05/29/2003US20030099648 Comprises monoclonal sheep-derived antibodies and engineered antibody constructs, such as humanized single-chain Fv fragments and chimeric antibodies
05/29/2003US20030099646 For interfering with cyclin expression or phosphorylation via map-kinase; hybridomas; antitumor agents; antiproliferative agents
05/29/2003US20030099644 CD40 ligand and CD40 agonist compositions and methods of use
05/29/2003US20030099643 Methods for selectively stimulating proliferation of t cells
05/29/2003US20030099642 Inhibiting activation by CD40 ligand (CD40L) of cells bearing CD40 on the cell surface, other than B cells, by contacting with an agent that inhibits the interaction between CD40L and the cells; treating autoimmune diseases, for example
05/29/2003US20030099638 Oligopeptide fragments of ICE (interleukin 1-beta converting enzyme) of given formula which act to inhibit ICE itself; for treating a neurodegenerative disorder
05/29/2003US20030099637 Remedies for interstitial pneumonia , method of constructing animal model of this disease, and screening method with the use of the same
05/29/2003US20030099631 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits
05/29/2003US20030099629 Recombinant onconase and chemical conjugates and fusion proteins of recombinant onconase
05/29/2003US20030099628 Preventing proliferation of a tumor, using heparinase III; use sequencing heparin-like glycosaminoglycans (HLGAGs), removing active heparan sulfate from a solution, inhibition of angiogenesis
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099626 Mixture of various Aspergillus derived enzymes such as protease, lipase, amylase and cellulase and mineral cofactors such as calcium, zinc, manganese, and magnesium compounds
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030099621 Screening cells to identify stem cells having a beneficial gene, and transplanting the cells into a patient to treat HIV or AIDS
05/29/2003US20030099618 Administering a genetic engineered virus virions, comprising a nucleotide sequence able to code antihemophilic factor protein; patient's blood will able to clot
05/29/2003US20030099617 Method for using thymosin beta-10 for gene therapy of solid malignant tumors
05/29/2003US20030099614 2-Methoxyestradiol-induced apoptosis in cancer cells
05/29/2003US20030099612 Genetic engineered human light chain polypeptide for treating disorders associated with cell proliferation; using agonists, antagonists, polynucleotide, or antibodies; specific binding
05/29/2003US20030099610 Novel uses of avian interferon gamma (ifn-y)
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099608 Human cytokine receptor
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314780A1 Collagen-binding hybrid polypeptide
05/28/2003EP1314436A4 Antiviral agent in the form of nose drops
05/28/2003EP1314436A1 Antiviral agent in the form of nose drops
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
05/28/2003EP1314037A2 Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
05/28/2003EP1313882A2 Diagnosis and treatment of prostate cancer
05/28/2003EP1313875A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
05/28/2003EP1313874A1 Pharmaceutical compositions comprising a modulator of adamts-1
05/28/2003EP1313857A2 Lipid metabolism molecules
05/28/2003EP1313855A2 Truncated bard1 protein, and its diagnostic and therapeutic uses
05/28/2003EP1313854A2 Transporters and ion channels
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313842A2 Human n-acetyltransferase family member and uses thereof
05/28/2003EP1313840A2 Isolated human drug-metabolizing proteins, nucleic acid molecules and uses thereof
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313768A2 Antisense oligonucleotides against vr1
05/28/2003EP1313767A2 Peptide with effects on cerebral health
05/28/2003EP1313766A2 Coaster, a human coactivator of steroid receptors
05/28/2003EP1313765A2 Secreted proteins and methods of using same
05/28/2003EP1313764A1 Crystal structure of a ras-pi3k complex
05/28/2003EP1313763A2 Method for the extraction and the use of antibiotically effective peptides for treating infectious diseases
05/28/2003EP1313762A2 Suppressor gene
05/28/2003EP1313761A1 18 human secreted proteins
05/28/2003EP1313760A2 Nucleotide sequences which code for the cita gene
05/28/2003EP1313753A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis
05/28/2003EP1313730A1 Pyrrolidine derivatives and their use as chymase inhibitor
05/28/2003EP1313514A2 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313510A2 Novel pharmaceutical composition
05/28/2003EP1313509A2 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents
05/28/2003EP1313507A2 Modulators of intermediate conductance calcium-activated potassium (ikca) channel activity for treating sexual dysfunction
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313503A1 Human tumor necrosis factor receptors tr21 and tr22
05/28/2003EP1313502A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS
05/28/2003EP1313501A2 Functions for dp214
05/28/2003EP1313500A2 Combinations of dalfopristine/quinupristine with cefpirome
05/28/2003EP1313499A1 Method for treating the central nervous system by administration of igf structural analogs
05/28/2003EP1313491A1 Bioactive fraction of eurycoma longifolia
05/28/2003EP1313488A1 Compositions and methods for improving cardiovascular function
05/28/2003EP1313476A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
05/28/2003EP1313453A1 Particulate vectors for improving oral absorption of active principles
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1313440A1 Dental products comprising bone growth enhancing peptide
05/28/2003EP1313399A2 Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid sac
05/28/2003EP1243275A4 Insulin-containing medicament for peroral application and method for the production thereof
05/28/2003EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP1165108B1 Use of a serenoa repens extract for the production of a medicament to treat prostate cancer
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1150664B1 Novel use of orexin receptor antagonists
05/28/2003EP1143983A4 Spray delivery of cells
05/28/2003EP1107749B1 Fumaric acid derivatives for the treatment of transplant rejection
05/28/2003EP1106626B1 Process for the preparation of regular glycopeptides
05/28/2003EP1066049B1 Pharmaceutical compositions for prolonged peptide release and preparation method
05/28/2003EP1039904B1 Synergistic antimicrobial compositions
05/28/2003EP1032415B1 Composition for the treatment of allergic conditions with cysteine and serine proteinase inhibitors
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0981358B1 Dolastatin-15 derivatives in combination with taxanes
05/28/2003EP0968227B1 Dimeric cationic lipids on dicystine basis
05/28/2003EP0938332A4 Use of delta-like protein to inhibit the differentiation of stem cells
05/28/2003EP0928294B1 Method and apparatus for preparing an acellular red blood cell substitute
05/28/2003EP0904097B1 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest
05/28/2003EP0871457B1 Isolated stromal cells and methods of using the same
05/28/2003EP0830604B1 Uses of apoptin
05/28/2003EP0826373B1 Use of lactoferrin for preventing postoperative astigmatism
1 ... 1838 1839 1840 1841 1842 1843 1844 1845 1846 1847 1848 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 ... 3163